Evidence map›Paper›PMID 41882170›Full record

ReviewRadiologie (Heidelberg, Germany)2026

[Soft tissue sarcoma of the extremities-imaging, biopsy planning, and pitfalls in radiology].

Timo Leichenich, Oliver Sedlaczek, Jonas Fehlinger, Sam Sedaghat, Burkhard Lehner, Andreas Geisbüsch, Christoph Rehnitz

Abstract readEnglish AbstractReview
PubMed Publisher
In one paragraph

Review in Radiologie (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Timo LeichenichKlinik für Diagnostische und Interventionelle Radiologie, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 420, 69120, Heidelberg, Deutschland.
Oliver SedlaczekKlinik für Diagnostische und Interventionelle Radiologie, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 420, 69120, Heidelberg, Deutschland.
Jonas FehlingerKlinik für Diagnostische und Interventionelle Radiologie, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 420, 69120, Heidelberg, Deutschland.
Sam SedaghatKlinik für Diagnostische und Interventionelle Radiologie, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 420, 69120, Heidelberg, Deutschland.
Burkhard LehnerKlinik für Orthopädie, Sektion Orthopädische Onkologie und Septische Orthopädische Chirurgie, Universitätsklinikum Heidelberg, Heidelberg, Deutschland.
Andreas GeisbüschKlinik für Orthopädie, Sektion Orthopädische Onkologie und Septische Orthopädische Chirurgie, Universitätsklinikum Heidelberg, Heidelberg, Deutschland.
Christoph RehnitzKlinik für Diagnostische und Interventionelle Radiologie, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 420, 69120, Heidelberg, Deutschland. christoph.rehnitz@med.uni-heidelberg.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRadiology is integral to the multimodal diagnostic and treatment pathway of extremity soft tissue sarcomas in DGK-certified sarcoma centers (DGK: Deutsche Krebsgesellschaft, German Cancer Society), working in close interdisciplinary collaboration with sarcoma surgery, pathology, radiation oncology, and medical oncology. GUIDELINE-BASED IMAGING AND TRIAGE: Treatment decisions rely on guideline- and recommendation-based imaging and histological confirmation by biopsy. When clinical warning signs (red flags) are present, radiological imaging is essential for triage and early referral to a sarcoma center. For local staging, magnetic resonance imaging (MRI) is the modality of choice. It provides crucial information for diagnosis, prognosis, and treatment within the sarcoma board and serves as the basis for adequate biopsy planning. MORPHOLOGICAL AND TECHNICAL PITFALLS: Diagnostic pitfalls arise from overlapping MRI appearances, particularly within the lipomatous spectrum and in lesions with myxoid and cystic patterns. A further focus is on avoidable procedural biopsy errors, inadequate targeting, and an inadequate biopsy tract that is not amenable to en bloc resection or that contaminates additional compartments/joints or neurovascular structures.

conclusionThe article outlines a risk-adapted diagnostic approach and provides practice-oriented principles for biopsy planning. It highlights typical problem MRI constellations to avoid misdiagnosis and underestimation of malignancy (grading), ultimately establishing optimal prerequisites for therapy.

Indexed as

ExtremitiesMagnetic Resonance ImagingSarcomaSoft Tissue NeoplasmsBiopsyDiagnostic ErrorsHumansNeoplasm StagingDiagnostic pitfallsImagingSoft tissue lesionsSoft tissue sarcomasTumour staging

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.